Comparative pharmacokinetic and pharmacodynamic response of single and double intraruminal doses of ivermectin and moxidectin in nematode-infected lambs

New Zealand Veterinary Journal

Volumn 63, Issue 4, 2015, Pages 227-234

  Lloberas, M ^a   Alvarez, L ^b   Entrocasso, C ^a   Ballent, M ^b   Virkel, G ^b   Luque, S ^b   Lanusse, C ^b   Lifschitz, A ^b  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

drug exposure; efficacy; ex vivo accumulation; Ivermectin; moxidectin; pharmacokinetics; resistant Haemonchus contortus

Indexed keywords

ANIMALIA; HAEMONCHUS CONTORTUS; NEMATODA; OVIS ARIES;

ANTHELMINTIC AGENT; IVERMECTIN; MACROLIDE; MILBEMYCIN;

ANIMAL; AREA UNDER THE CURVE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; HAEMONCHIASIS; HALF LIFE TIME; PARASITOLOGY; SHEEP; SHEEP DISEASES; VETERINARY;

ANIMALS; ANTHELMINTICS; AREA UNDER CURVE; DRUG ADMINISTRATION SCHEDULE; HAEMONCHIASIS; HALF-LIFE; IVERMECTIN; MACROLIDES; SHEEP; SHEEP DISEASES;

EID: 84931560101     PISSN: 00480169     EISSN: 11760710     Source Type: Journal    
DOI: 10.1080/00480169.2015.1015645     Document Type: Article

References (35)

1. L.I.Alvarez, S.F.Sanchez, C.E.Lanusse. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetics behaviour in sheep. Journal of Veterinary Pharmacology and Therapeutics 22, 77–86, 1999 doi: 10.1046/j.1365-2885.1999.00194.x
2. L.I.Alvarez, M.L.Mottier, S.F.Sanchez, C.E.Lanusse. Ex vivo diffusion of albendazole and its sulphoxide metabolite into Ascaris suum and Fasciola hepatica. Parasitology Research 87, 929–34, 2001
3. *Anonymous. MAF User's Guide. The New Zealand Animal Welfare Act, MAF Biosecurity, Wellington, New Zealand, 1999
4. E.H.Barnes, R.J.Dobson, P.A.Stein, L.F.Le Jambre, I.J.Lenane. Selection of different genotype larvae and adult worms for anthelmintic resistance by persistent and short-acting avermectin/milbemycins. International Journal for Parasitology 31, 720–7, 2001 doi: 10.1016/S0020-7519(01)00174-6
5. H.Bártíková, I.Vokřál, V.Kubíček, B.Szotáková, L.Prchal, J.Lamka, M.Várady, L.Skálová. Import and efflux of flubendazole in Haemonchus contortus strains susceptible and resistant to anthelmintics. Veterinary Parasitology 187, 473–9, 2012 doi: 10.1016/j.vetpar.2012.02.008
6. G.C.Coles, F.H.M.Bauer, S.Borgsteede, T.R.Geerst, T.R.Klei, M.A.Taylor, P.J.Waller. World association for the advancement of veterinary parasitology (WAAVP). Methods for detection of anthelmintic resistance in nematodes of veterinary importance. Veterinary Parasitology 44, 35–44, 1992 doi: 10.1016/0304-4017(92)90141-U
7. J.Demeler, J.H.Gill, G.von Samson-Himmelstjerna, N.C.Sangster. The in vitro assay profile of macrocyclic lactone resistance in three species of sheep trichostrongyloids. International Journal for Parasitology: Drugs and Drug Resistance 3, 109–18, 2013
8. J.Demeler, G.Von Samson-Himmelstjerna, N.C.Sangster. Measuring the effect of avermectins and milbemycins on somatic muscle contraction of adult Haemonchus contortus and on motility of Ostertagia circumcincta in vitro. Parasitology 141, 948–56, 2014 doi: 10.1017/S0031182013002291
9. P.De Montigny, J.-S.K.Shim, J.V.Pivinichny. Liquid chromatographic determination of ivermectin in animal plasma with trifluoro-acetic anhydride and N-methylimidazole as the derivatization reagent. Journal of Pharmaceutical and Biomedical Analysis 8, 507–11, 1990 doi: 10.1016/0731-7085(90)80060-3
10. C.Entrocasso, L.Alvarez, J.Manazza, A.Lifschitz, B.Borda, G.Virkel, L.Mottier, C.Lanusse. Clinical efficacy assessment of the albendazole–ivermectin combination in lambs parasitized with resistant nematodes. Veterinary Parasitology 155, 249–56, 2008 doi: 10.1016/j.vetpar.2008.04.015
11. M.*Gibaldi, D.Perrier. Pharmacokinetics. 2nd Edtn. Marcel Dekker Inc., New York, USA, 1982
12. R.M.Gopal, D.M.West, W.E.Pomroy. The difference in efficacy of ivermectin oral, moxidectin oral and moxidectin injectable formulations against an ivermectin-resistant strain of Trichostrongylus colubriformis in sheep. New Zealand Veterinary Journal 49, 133–7, 2001 doi: 10.1080/00480169.2001.36220
13. D.Hennessy. Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds. Veterinary Parasitology 72, 367–90, 1997 doi: 10.1016/S0304-4017(97)00106-4
14. R.E.Hibbs, E.Gouaux. Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 474, 54–60, 2011 doi: 10.1038/nature10139
15. N.H.Holford, L.B.Sheiner. Understanding the dose–effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clinical Pharmacokinetics 6, 429–53, 1981 doi: 10.2165/00003088-198106060-00002
16. R.M.Kaplan, A.N.Vidyashankar. An inconvenient truth: global warming and anthelmintic resistance. Veterinary Parasitology 186, 70–8, 2012 doi: 10.1016/j.vetpar.2011.11.048
17. A.C.Kotze, B.M.Hines, A.P.Ruffell. A reappraisal of the relative sensitivity of nematode pharyngeal and somatic musculature to macrocyclic lactone drugs. International Journal for Parasitology: Drugs and Drug Resistance 2, 29–35, 2012
18. A.C.Kotze, A.P.Ruffell, M.R.Knox, G.A.Kelly. Relative potency of macrocyclic lactones in in vitro assays with larvae of susceptible and drug-resistant Australian isolates of Haemonchus contortus and H. placei. Veterinary Parasitology 203, 294–302, 2014 doi: 10.1016/j.vetpar.2014.04.005
19. C.Lanusse, R.Prichard. Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics. Veterinary Parasitology 49, 123–58, 1993 doi: 10.1016/0304-4017(93)90115-4
20. D.M.Leathwick. Modelling the benefits of a new class of anthelmintic in combination. Veterinary Parasitology 186, 93–100, 2012 doi: 10.1016/j.vetpar.2011.11.050
21. D.M.Leathwick, B.C.Hosking. Managing anthelmintic resistance: modelling strategic use of a new anthelmintic class to slow the development of resistance to existing classes. New Zealand Veterinary Journal 57, 203–7, 2009 doi: 10.1080/00480169.2009.36902
22. D.M.Leathwick, C.M.Miller. Efficacy of oral, injectable and pour-on formulations of moxidectin against gastrointestinal nematodes in cattle in New Zealand. Veterinary Parasitology 191, 293–300, 2013 doi: 10.1016/j.vetpar.2012.09.020
23. A.Lifschitz, G.Virkel, A.Pis, F.Imperiale, S.Sanchez, L.Alvarez, R.Kujanek, C.Lanusse. Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation.to cattle. Veterinary Parasitology 86, 203–15, 1999 doi: 10.1016/S0304-4017(99)00142-9
24. A.Lifschitz, G.Virkel, J.Sallovitz, J.F.Sutra, P.Galtier, M.Alvinerie, C.Lanusse. Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle. Veterinary Parasitology 87, 327–38, 2000 doi: 10.1016/S0304-4017(99)00175-2
25. A.Lifschitz, C.Entrocasso, L.Alvarez, M.Lloberas, M.Ballent, J.Manazza, G.Virkel, B.Borda, C.Lanusse. Interference with P-glycoprotein improves ivermectin activity against adult resistant nematodes in sheep. Veterinary Parasitology 172, 291–8, 2010 doi: 10.1016/j.vetpar.2010.04.039
26. A.Lifschitz, M.Ballent, G.Virkel, J.Sallovitz, P.Viviani, L.Mate, C.Lanusse. Accumulation of monepantel and its sulphone derivative in tissues of nematode location in sheep -pharmacokinetic support to its excellent nematodicidal activity. Veterinary Parasitology 203, 120–6, 2014 doi: 10.1016/j.vetpar.2014.02.049
27. M.Lloberas, L.Alvarez, C.Entrocasso, G.Virkel, C.Lanusse, A.Lifschitz. Measurement of ivermectin concentrations in target worms and host gastrointestinal tissues: influence of the route of administration on the activity against resistant Haemonchus contortus in lambs. Experimental Parasitology 131, 304–9, 2012 doi: 10.1016/j.exppara.2012.04.014
28. M.Lloberas, L.Alvarez, C.Entrocasso, G.Virkel, M.Ballent, L.Mate, C.Lanusse, A.Lifschitz. Comparative tissue pharmacokinetics and efficacy of moxidectin, abamectin and ivermectin in lambs infected with resistant nematodes: impact of drug treatments on parasite P-glycoprotein expression. International Journal for Parasitology: Drugs and Drug Resistance 3, 20–7, 2013
29. C.G.Mackintosh, C.Cowie, K.Fraser, P.Johnstone, P.C.Mason. Reduced efficacy of moxidectin and abamectin in young red deer (Cervus elaphus) after 20 years of moxidectin pour-on use on a New Zealand deer farm. Veterinary Parasitology 199, 81–92, 2014 doi: 10.1016/j.vetpar.2013.09.028
30. M.N.Martinez. Bioequivalence accomplishments, ongoing initiatives, and remaining challenges. Journal of Veterinary Pharmacology and Therapeutics 37, 2–12, 2014 doi: 10.1111/jvp.12063
31. P.B.McKenna. Use of arithmetic and geometric means in the calculation of anthelmintic efficacy. Veterinary Record 141, 472–3, 1997 doi: 10.1136/vr.141.18.472
32. M.L.Mottier, L.I.Alvarez, L.Ceballos, C.E.Lanusse. Drug transport mechanism in helminth parasites: passive diffusion of benzimidazole anthelmintics. Experimental Parasitology 113, 49–57, 2006 doi: 10.1016/j.exppara.2005.12.004
33. R.Prichard, C.Menez, A.Lespine. Moxidectin and the avermectins: consanguinity but not identity. International Journal for Parasitology: Drugs and Drug Resistance 2, 134–53, 2012
34. M.Vickers, M.Venning, P.B.McKenna, B.Mariadass. Resistance to macrocyclic lactone anthelmintics by Haemonchus contortus and Ostertagia circumcincta in sheep in New Zealand. New Zealand Veterinary Journal 49, 101–5, 2001 doi: 10.1080/00480169.2001.36211
35. I.B.Wood, N.K.Amaral, K.Bairden, J.L.Duncan, T.Kassai, J.B.Malone, J.A.Pankavich, R.K.Reinecke, O.Slocombe, S.M.Taylor,. World association for the advancement of veterinary parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine). Veterinary Parasitology 58, 181–213, 1995 doi: 10.1016/0304-4017(95)00806-2